Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Tacrolimus and Prograf in Healthy Volunteers
NCT04725682Phase 1Completed
- Sponsor
- Food and Drug Administration
- Start
- Jan 2021
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tacrolimus + Wuzhi capsule in organ transplant rejection, sponsored by Food and Drug Administration. Started Jan 2021; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
organ transplant rejection
Beyond the preview
Go deeper on NCT04725682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04725682.